Is Abbott Laboratories (ABT) a Stock to Watch After Losing -2.41% This Week?

Abbott Laboratories (ABT) stock is down 2.41% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Abbott Laboratories has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ABT!

See Full ABT Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With ABT Stock Today?

Abbott Laboratories (ABT) stock is trading at $101.69 as of 3:24 PM on Friday, Jun 9, a gain of $0.91, or 0.9% from the previous closing price of $100.78. The stock has traded between $100.54 and $101.98 so far today. Volume today is light. So far 2,837,187 shares have traded compared to average volume of 4,370,199 shares.

More About Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. Click Here to get the full Stock Report for Abbott Laboratories stock.